Brain capillary tissue plasminogen activator in a diabetes stroke model

Stroke

Volumn 27, Issue 4, 1996, Pages 712-719

  Kittaka, Mamoru ^a   Wang, Liang ^a   Sun, Ning ^a   Schreiber, Steven S ^a   Seeds, Nicholas W ^c   Fisher, Mark ^a   Zlokovic, Berislav V ^a,b,d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d NONE   (United States)

Author keywords

cerebral blood flow; cerebral ischemia; diabetes mellitus; hyperglycemia; rats; tissue plasminogen

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD FLOW; BRAIN CAPILLARY; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DIABETES MELLITUS; FIBRINOLYSIS; HYPERGLYCEMIA; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROKE; TRANSCRIPTION REGULATION; VASCULAR ENDOTHELIUM;

EID: 0029915577     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.4.712     Document Type: Article

References (41)

1. Collen D. On the regulation and control of fibrinolysis. Thromb Haemost. 1980;43:77-89.
2. Francis RB Jr. Clinical disorders of fibrinolysis: a critical review. Blut. 1989;59:1-14.
3. Gilboa N, Kaplan JE. Plasma fibronectin enhances fibrinolytic system in vitro. Thromb Haemost. 1985;54:639-644.
4. van Hinsbergh VW, Kooistra T, Emeis JJ, Koolwijk P. Regulation of plasminogen activator production by endothelial cells: role in fibrinolysis and local proteolysis. Int J Radiat Biol. 1991;60:261-272.
5. Kollros PR, Konkle BA, Ambarian AP, Henrikson P. Plasminogen activator inhibitor-1 expression by brain microvessel endothelial cells is inhibited by elevated glucose. J Neurochem. 1994;63:903-909.
6. Zlokovic BV, Wang L, Sun N, Haffke S, Verrall S, Seeds NW, Fisher M, Schreiber SS. Expression of tissue plasminogen activator in cerebral capillaries: possible fibrinolytic function of the blood-brain barrier. Neurosurgery. 1995;37:955-961.
7. Levine SR, Brott TG. Thrombolytic therapy in cerebrovascular disorders. Prog Cardiovasc Dis. 1992;34:235-262.
8. Gross CE, Raymond AS, Howard DB, Bednar MM. Delayed tissue-plasminogen activator therapy in a rabbit model of thromboembolic stroke. Neurosurgery. 1995;36:1172-1177.
9. Fisher M, Francis R. Altered coagulation in cerebral ischemia: platelet, thrombin, and plasmin activity. Arch Neurol. 1990;47:1075-1079.
10. Zlokovic BV, Wang L, Schreiber SS, Fisher M. Hemostatic functions of the blood-brain barrier: possible implications in the pathogenesis of stroke. In: Greenwood J, Begley DJ, Segal MB, eds. New Concepts of the Blood-Brain Barrier. New York, NY: Plenum Press; 1995:141-145.
11. Zlokovic BV, Wang L, Schreiber SS, Fisher M. Downregulation of tissue plasminogen activator at the blood-brain barrier in diabetic rats. Stroke. 1995;26:166. Abstract.
12. Zlokovic BV, Mackic BV, Wang L, McComb JG, McDonough A. Differential expression of Na,K-ATP-ase α and β subunit isoforms at the blood-brain barrier and the choroid plexus. J Biol Chem. 1993;268:8019-8025.
13. Friedman GC, Seeds NW. Tissue plasminogen activator expression in the embryonic nervous system. Dev Brain Res. 1994;81:41-49.
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
15. Ny T, Leonardsson G, Hsueh AJW. Cloning and characterization of a cDNA for rat tissue-type plasminogen activator. DNA. 1988;7:671-677.
16. Zea Longa E, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20:84-91.
17. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab. 1990;10:290-295.
18. Freeman SN, Rennie PS, Chao J, Lund LR, Andreasen PA. Urokinase- and tissue-type plasminogen activators are suppressed by cortisol in the involuting prostate of castrated rats. Biochem J. 1990;269:189-193.
19. Pennica D, Holmes WE, Kohr WJ, Harkins RN, Vehar GA, Ward CA, Bennett WF, Yelverton E, Seeburg PH, Heyneker HL, Goeddel DV, Collen D. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature. 1983;301:214-220.
20. Diamond SL, Sharefkin JB, Dieffenbach C, Frasier-Scott K, McIntrie LV, Eskin SG. Tissue plasminogen activator messenger RNA levels increase in cultured human endothelial cells exposed to laminar shear stress. J Cell Physiol. 1990;143:364-371.
21. Iba T, Shin T, Sonoda T, Rosales O, Sumpio BE. Stimulation of endothelial secretion of tissue-type plasminogen activator by repetitive stretch. J Surg Res. 1991;50:457-460.
22. Levin EG, Santell L, Saljooque F. Hyperosmotic stress stimulates tissue plasminogen activator expression by a PKC-independent pathway. Am J Physiol. 1993;265:C387-C396.
23. Zimmerman GA, Meistrell M III, Bloom O, Cockroft KM, Blanchi M, Risucci D, Broome J, Farmer P, Cerami A, Vlassar H, Tracey K. Neurotoxicity of advanced glycation end products during focal stroke and neuroprotective effects of aminoguanidine. Proc Natl Acad Sci U S A. 1995;92:3744-3748.
24. Huijberts MS, Wolffenbuttel BH, Crijns FR, Nieuwenhuijzen-Kruseman AC, Bemelmans MH, Struijker-Boudier HA. Amino-guanidine reduces regional albumin clearance but not urinary albumin excretion in streptozotocin-diabetic rats. Diabetologia. 1994; 37:10-14.
25. Nakajima S, Yoshimine T, Kato A, Kumura E, Takemoto O, Hayakawa T. The effect of tPA on the microcirculatory disturbance in experimental cerebral ischemia. J Cereb Blood Flow Metab. 1993; 13:S183-S184.
26. Pulsinelli WA, Waldman S, Rawlinson D, Plum F. Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology. 1982;32:1239-1246.
27. Warner DS, Smith M-L, Siesjo BK. Ischemia in normo- and hyperglycemic rats: effects on brain water and electrolytes. Stroke. 1990; 21:758-764.
28. Ginsberg MD, Welsh FA, Budd WW. Deleterious effect of glucose pretreatment on recovery from diffuse cerebral ischemia in the cat. Stroke. 1980;11:347-355.
29. Paljarvi L, Rechncrona S, Soderfeldt B, Olsson Y, Kalimo H. Brain lactic acidosis and ischemic cell damage: quantitative ultrastructural changes in capillaries of rat cerebral cortex. Acta Neuropathol (Berl). 1983;60:232-240.
30. Ginsberg MD, Prado R, Dietrich WD, Busto R, Watson BD. Hyperglycemia reduces the extent of cerebral infarction in rats. Stroke. 1987;18:570-574.
31. Zasslow MA, Pearl RG, Shuer LM, Steinberg GK, Lieberson RE, Larson CP. Hyperglycemia decreases acute neuronal ischemic changes after middle cerebral artery occlusion in cats. Stroke. 1989; 20:519-523.
32. Nedergaard M, Diemer NH. Focal ischemia of the rat brain with special reference to the influence of plasma glucose concentration. Acta Neuropathol (Berl). 1987;73:131-137.
33. de Courten-Myers GM, Myers RE, Schoolfield L. Hyperglycemia enlarges infarct size in cerebrovascular occlusion in cats. Stroke. 1988;19:623-630.
34. Prado R, Ginsberg MD, Dietrich WD, Watson BD, Busto R. Hyperglycemia increases infarct size in collaterally perfused but not end-arterial vascular territories. J Cereb Blood Flow Metab. 1988;8: 186-192.
35. de Courten-Myers GM, Kleinholz M, Wagner KR, Myers RE. Fatal strokes in hyperglycemic cats. Stroke. 1989;20:1707-1715.
36. Yip PK, He YY, Hsu CY, Garg N, Marangos P, Hogan EL. Effect of plasma glucose on infarct size in focal cerebral ischemia-reperfusion. Neurology. 1991;41:899-905.
37. Nedergaard M. Transient focal ischemia in hyperglycemic rats is associated with increased cerebral infarction. Brain Res. 1987;408: 79-85.
38. Duverger D, Mackenzie E. The quantification of cerebral infarction following focal ischemia in the rat: influence of strain, arterial pressure, blood glucose concentration, and age. J Cereb Blood Flow Metab. 1988;8:449-461.
39. Lasarsere CA, Pitts D, Nelson DR, Faulk PW. Vascular tissue plasminogen activator and the development of coronary artery disease in heart-transplant recipients. N Engl J Med. 1995;333: 1111-1116.
40. Levin EG, del Zoppo GJ. Localization of tissue plasminogen activator in the endothelium of a limited number of vessels. Am J Pathol. 1994;144:855-861.
41. Shatos MA, Orfeo T, Doherty JM, Penar PL, Collen D, Mann KG. α-Thrombin stimulates urokinase production and DNA synthesis in cultured human cerebral microvascular endothelial cells. Arterioscler Thromb Vasc Biol. 1995;15:901-911.